Supercharge site selection and feasibility with AI Site Twins of every research site on the planet
Ryght AI's generative AI platform enables sponsors and CROs to quickly find, select, and activate the best sites for their study protocols — and continuously optimize site performance after activation.

Supercharge site selection and feasibility with AI digital twins of every research site on the planet
Ryght AI's generative AI platform enables sponsors and CROs to quickly find, select, and activate the best sites for their study protocols — and continuously optimize site performance after activation.


Traditional site selection and feasibility methods are outdated, inefficient and expensive
Sponsors and CROs are still relying on outdated spreadsheets of disparate data to evaluate sites, and assessing feasibility is plagued by guesswork and slow response times.

Identify the best sites, activate faster and start enrollment sooner
Ryght AI rapidly analyzes your protocol and then instantly connects you with high-potential research sites—anywhere in the world.
Our technology streamlines site selection, accelerates activation, gets your studies enrolling patients sooner than traditional approaches, then optimizes site performance for the duration of the trial.
Identify the best sites, activate faster and start enrollment sooner
Ryght AI rapidly analyzes your protocol and then instantly connects you with high-potential research sites—anywhere in the world.
Our technology streamlines site selection, accelerates activation, gets your studies enrolling patients sooner than traditional approaches, then optimizes site performance for the duration of the trial.

What are AI Site Twins?
Ryght's AI Site Twins are digital replicas of every clinical research site in the world. Built on the established concept of digital twins, these virtual representations capture a site's unique operational characteristics, historical trial performance, and patient populations.
This powerful AI-powered platform provides sponsors and CROs with the predictive capabilities they need to enhance site selection, feasibility, and study optimization throughout the life of the trial.

Ingest + Analyze
Leverage advanced AI and machine learning algorithms to analyze complex datasets and identify patterns in seconds.

Simulate + Forecast
Run potential scenarios to predict enrollment performance and anticipate potential issues or opportunities

Dynamic + Interactive
Every twin is constantly updated by AI retriever agents with real-time data from public and other sources, reflecting changes in the physical world.

Optimize + Adapt
Adjust protocol parameters in real-time based on emerging data, leading to more efficient and successful trials.
A complete, dynamic data-derived replica of every clinical research site on the planet


A complete, dynamic data-derived replica of every clinical research site on the planet

Explore the Ryght AI platform

Upload your protocol, and Ryght will instantly analyze our global network of AI Site Twins to identify the best-fit clinical research sites for your study.

Automatically send qualified sites pre-populated feasibility questionnaires powered by data from our AI Site Twin network. All sites need to do is review and approve - saving weeks of wait time.
Available on the Microsoft Azure Marketplace
Ryght is available on Microsoft Azure Marketplace, making it easy for sponsors and CROs to use existing cloud commitments, simplify billing, and increase cost efficiency.

Discover the difference AI-powered site selection and feasibility can make.
Skeptical? We get it. AI-powered site selection in minutes does sound a little too good to be true. That's why we’re ready to demonstrate Ryght’s capabilities for you in real time.
Just give us twenty minutes and an old protocol, and we'll show you how quickly Ryght finds the best-fit sites for your trial before you finish your coffee.
Trusted by top healthcare and research companies worldwide
"By streamlining study selection, feasibility, and patient referrals, the Ryght Research Network will allow us to focus more on advancing patient care and less on administrative burden while running the trials that are most likely to succeed."
"Ryght Al's unique and powerful platform streamlines clinical trials from site selection to activation nd enrollment, ultimately speeding up time to market for our biopharma clients."
"At the University of Adelaide, we are committed to advancing world-class research that addresses many of the challenges faced by society. By working together, we can leverage our collective expertise to develop innovative, responsible and tested solutions for better public health and other critical issues and bring Australia's Al capabilities up to world-class standards where they belong."
Stay Connected
Subscribe to be the first to know about product updates, news and announcements.